CR6351A - IMPROVED GROWTH STIMULATING COMPOSITIONS - Google Patents

IMPROVED GROWTH STIMULATING COMPOSITIONS

Info

Publication number
CR6351A
CR6351A CR6351A CR6351A CR6351A CR 6351 A CR6351 A CR 6351A CR 6351 A CR6351 A CR 6351A CR 6351 A CR6351 A CR 6351A CR 6351 A CR6351 A CR 6351A
Authority
CR
Costa Rica
Prior art keywords
growth stimulating
improved growth
improved
stimulating compositions
formulation
Prior art date
Application number
CR6351A
Other languages
Spanish (es)
Inventor
S Robins Daniel
Chung Shiu
J Kennedy Thomas
James Knight Peter
Jese Shao Zezhi
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CR6351A publication Critical patent/CR6351A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN ESTIMULANTE DEL CRECIMIENTO Y DEL PESO MEJORADO PARA ANIMALES DOMESTICADOS COMO SER GANADO, CERDOS Y OVEJAS ESTA COMPUESTO POR UN AGENTE ANABOLICO QUE ES ADMINISTRADO SUBCUTANEAMENTE EN LA FORMA DE UNA FORMULACION DE IMPLANTE DE LIBERACION DUAL. LOS AUMENTOS INCREMENTADOS SON PARTICULARMENTE MEJORADOS CUANDO SE ADMINISTRA ZERANOL EN UNA FORMULACION DE LIBERACION INMEDIATA Y DE LIBERACION CONTROLADA QUE PERMITE UNA INYECCION DE DOSIFICACION DE UNA VEZ.GROWTH stimulant WEIGHT AND IMPROVED FOR HOW TO BE WON domesticated animals, pigs and sheep consists of an Anabolic Agent WHAT IS ADMINISTERED subcutaneously in the form of a formulation OF DUAL release implant. INCREASED INCREASES ARE PARTICULARLY IMPROVED WHEN ZERANOL IS ADMINISTERED IN AN IMMEDIATE RELEASE AND CONTROLLED RELEASE FORMULATION THAT ALLOWS A DOSAGE INJECTION ONCE.

CR6351A 1998-11-04 2001-04-20 IMPROVED GROWTH STIMULATING COMPOSITIONS CR6351A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
CR6351A true CR6351A (en) 2003-11-20

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6351A CR6351A (en) 1998-11-04 2001-04-20 IMPROVED GROWTH STIMULATING COMPOSITIONS

Country Status (11)

Country Link
AR (1) AR025133A1 (en)
AU (1) AU777393B2 (en)
BR (2) BR9914996A (en)
CA (1) CA2348841C (en)
CO (1) CO5140100A1 (en)
CR (1) CR6351A (en)
MY (1) MY134868A (en)
PE (1) PE20001092A1 (en)
TW (1) TWI250027B (en)
WO (1) WO2000025743A2 (en)
ZA (1) ZA200103494B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
ES2948624T3 (en) 2020-11-19 2023-09-14 Fis Fabbrica Italiana Sintetici Spa Improved process for the preparation of trenbolone and/or trenbolone acetate
EP4001288A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
EP4000688A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (en) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog EXTENDED RELEASE ANABOLIZING IMPLANTS
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
CA2348841A1 (en) 2000-05-11
BRPI9914996B1 (en) 2011-11-01
CA2348841C (en) 2007-04-17
BRPI9914996A (en) 2001-07-10
MY134868A (en) 2007-12-31
BR9914996A (en) 2001-07-10
ZA200103494B (en) 2002-07-30
CO5140100A1 (en) 2002-03-22
WO2000025743A2 (en) 2000-05-11
BRPI9914996B8 (en) 2021-07-06
TWI250027B (en) 2006-03-01
AU777393B2 (en) 2004-10-14
AU3096700A (en) 2000-05-22
PE20001092A1 (en) 2000-10-31
WO2000025743A3 (en) 2000-08-24
AR025133A1 (en) 2002-11-13

Similar Documents

Publication Publication Date Title
NI200500087A (en) DERIVATIVES 4-TETRAZOLYL-4 PHENYLPIPERIDINE FOR PAIN TREATMENT
AR045142A1 (en) BUEN SABOR DUCTILE MASTICABLE VETERINARY COMPOSITION
BRPI0412211A (en) controlled release compositions
AR026986A1 (en) PHARMACEUTICAL IMPLANT WITH CONTENT OF IMMEDIATE RELEASE AND SUSTAINED RELEASE COMPONENTS AND METHODS OF ADMINISTRATION
AR014231A1 (en) OSMOSTIC ADMINISTRATION DEVICE FOR THE ADMINISTRATION OF A BENEFICIAL AGENT TO AN ANIMAL.
SE0002754D0 (en) New pharmaceutical combination formulation and method of treatment with the combination
ECSP045407A (en) BENZAZOLES SUBSTITUTED AND THE USE OF THE SAME AS INHIBITORS OF QUINASA RAF
AR098251A2 (en) USE OF AIVLOSIN OR AN ACID ADDITION SALT OF THE SAME PHARMACOLOGICALLY ACCEPTED FOR THE PREPARATION OF A VETERINARY USE MEDICINAL PRODUCT, A FOOD FOR CORRAL BIRDS OR PIGS, A STABLE COVERED COMPOSITION TO BE ADDED TO THIS FOOD
DK0862416T3 (en) Non-polymeric delayed release administration system
AR044234A2 (en) USE OF A COMPOSITION THAT INCLUDES LIVE EIMERY EARNINGS
SV2008002466A (en) OBLEA CONTAINING STEROID HORMONES REF. P-SV-79.953 / GH
AR044236A2 (en) USE OF A COMPOSITION THAT INCLUDES LIVING EIMERIA SPORTS
CR6351A (en) IMPROVED GROWTH STIMULATING COMPOSITIONS
CA2568641A1 (en) Sustained release composition
AR048806A1 (en) USE OF CARIOFILENES IN THE PREPARATION OF MEDICINES AND TREATMENT OF BODY INFLAMMATION AND INFLAMMATORY PAIN AFFECTIONS
AR019579A1 (en) USE OF AN INITIATOR OF THE SEXUAL RESPONSE OF THE CENTRAL NERVOUS SYSTEM FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE STANDARDIZATION OF THE CHRONOMETRATION OF THE SEXUAL RESPONSE OR FOR THE PROPHYLAXIS OR REDUCTION OF THE MULTIFUL LESIAN NUMBER
AR039895A1 (en) COMPOSITION THAT INCLUDES A VITAMIN, A METAL SALT AND AN INSULIN OR A HORMONE OF THE GROWTH AND USE OF SUCH COMPONENTS TO PREPARE IT
ECSP993205A (en) IMPROVED GROWTH STIMULATING COMPOSITIONS (CASE AHO948)
AU2011284658A1 (en) Compositions for treating heartworm infestation
Gómez-Fernández et al. The effect of immunocastration and surgically castration on growth performance and carcass quality in fattening period of Iberian female pigs.
AR037543A1 (en) METHOD FOR CANCER THERAPY AND PHARMACEUTICAL COMPOSITION
Patrizi et al. Generalized reaction to subcutaneous heparin.
CN110664806A (en) Fipronil and methoprene glycol plastid and preparation method and application thereof
TH48412A3 (en) Growth stimulant composition That has been updated
Godbold Jr et al. Contraindications, Special Considerations, and Precautions

Legal Events

Date Code Title Description
FC90 Application suspended